Volume 8, Supplement 1 (Jul/Aug 2017)
Lung cancer is the leading cause of cancer-associated mortality and late diagnosis is a fundamental obstacle to improving outcomes in lung cancer, exacerbating the unmet medical need for APs to maintain a continually high educational status about increasingly complex diagnostics and treatment options. This activity will provide education to assist APs in closing or narrowing this medical gap, providing a better understanding of the use of targeted and immunotherapies as they apply to the management of NSCLC.
